Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 269268, 4 pages
http://dx.doi.org/10.1155/2013/269268
Case Report

Multicentric Castleman’s Disease, Associated with Idiopathic Thrombocytopenic Purpura

1Fairview Hospital, Cleveland Clinic Health System, Cleveland, OH 44111, USA
2Case Western University School of Medicine, Cleveland, OH 44111, USA
3Hematology-Oncology, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OH 44111, USA

Received 25 April 2013; Accepted 27 May 2013

Academic Editors: E. Bissé, R. Herrmann, M.-C. Kyrtsonis, and A. Ohsaka

Copyright © 2013 Ruchi Sood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Castleman and V. W. Towne, “Case records of the Massachusetts General Hospital: case no. 40231,” The New England Journal of Medicine, vol. 250, pp. 1001–1005, 1954. View at Publisher · View at Google Scholar
  2. B. Castleman, L. Iverson, and V. P. Menendez, “Localized mediastinal lymph node hyperplasia resembling thymoma,” Cancer, vol. 9, pp. 822–830, 1956. View at Google Scholar
  3. B. Roca, “Castleman's disease: a review,” AIDS Reviews, vol. 11, no. 1, pp. 3–7, 2009. View at Google Scholar · View at Scopus
  4. I. S. Izuchukwu, K. Tourbaf, and M. C. Mahoney, “An unusual presentation of Castleman's disease: a case report,” BMC Infectious Diseases, vol. 3, article 20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Bonekamp, K. M. Horton, R. H. Hruban, and E. K. Fishman, “Castleman disease: the great mimic,” Radiographics, vol. 31, no. 6, pp. 1793–1807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. D. Weisenburger, B. N. Nathwani, C. D. Winberg, and H. Rappaport, “Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases,” Human Pathology, vol. 16, no. 2, pp. 162–172, 1985. View at Google Scholar · View at Scopus
  7. B. Castleman, L. Iverson, and V. P. Menendez, “Localized mediastinal lymph node hyperplasia resembling thymoma,” Cancer, vol. 9, no. 4, pp. 822–830, 1956. View at Google Scholar
  8. H. L. Tey and M. B. Y. Tang, “A case of paraneoplastic pemphigus associated with Castleman's disease presenting as erosive lichen planus,” Clinical and Experimental Dermatology, vol. 34, no. 8, pp. e754–e756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Guihot, L. J. Couderc, F. Agbalika et al., “Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study,” European Respiratory Journal, vol. 26, no. 1, pp. 118–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Lowenthal, D. A. Filippa, M. E. Richardson, M. Bertoni, and D. J. Straus, “Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man,” Cancer, vol. 60, no. 10, pp. 2454–2458, 1987. View at Google Scholar · View at Scopus
  11. A. Waterston and M. Bower, “Fifty years of multicentric Castleman's disease,” Acta Oncologica, vol. 43, no. 8, pp. 698–704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Frizzera, “Castleman's disease and related disorders,” Seminars in Diagnostic Pathology, vol. 5, no. 4, pp. 346–364, 1988. View at Google Scholar · View at Scopus
  13. K. D. Markou, J. K. Goudakos, G. Psillas et al., “Castleman's disease of the neck: report of a case and review of the literature,” B-ENT, vol. 5, no. 3, pp. 189–193, 2009. View at Google Scholar · View at Scopus
  14. J. T. Beck, S. M. Hsu, J. Wijdenes et al., “Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody,” New England Journal of Medicine, vol. 330, no. 9, pp. 602–605, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Lee, D. H. Kim, and B. S. Son, “Castleman's disease with myasthenia gravis,” The Korean Journal of Thoracic and Cardiovascular Surgery, vol. 45, no. 3, pp. 199–201, 2012. View at Google Scholar
  16. A. Muela Molinero, B. Ballesteros del Rio, V. Sandoval Guerra, and J. Llor Baños, “Evans syndrome as presentation of multicenter Castleman disease,” Revista Clinica Espanola, vol. 203, no. 12, pp. 616–617, 2003. View at Google Scholar · View at Scopus
  17. J. H. Marsh, D. S. Colbourn, V. Donovan, and H. Staszewski, “Systemic Castleman's disease in association with Evan's syndrome and vitiligo,” Medical and Pediatric Oncology, vol. 18, no. 2, pp. 169–172, 1990. View at Google Scholar · View at Scopus
  18. M. H. Thoufeeq and M. J. Perry, “Castleman's disease in a patient with celiac disease,” Indian Journal of Gastroenterology, vol. 26, no. 4, article 187, 2007. View at Google Scholar · View at Scopus
  19. M. Loy, E. Perra, P. Siotto et al., “Gray-scale and color Doppler sonographic findings in a case of mesenteric Castleman's disease incidentally detected in a patient with Graves' disease,” Journal of Clinical Ultrasound, vol. 33, no. 7, pp. 356–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Browne, E. N. Barton, K. O. Barrow, N. P. Williams, and B. Hanchard, “Multicentric angiofollicular lymph node hyperplasia in ulcerative colitis: a case report,” West Indian Medical Journal, vol. 45, no. 1, pp. 34–36, 1996. View at Google Scholar · View at Scopus
  21. K. Higashi, Y. Matsuki, T. Hidaka, S. Aida, K. Suzuki, and H. Nakamura, “Primary Sjogren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia,” Scandinavian Journal of Rheumatology, vol. 26, no. 6, pp. 482–484, 1997. View at Google Scholar · View at Scopus
  22. K. Ibrahim, I. Maghfoor, A. Elghazaly, N. Bakshi, S. Y. Mohamed, and M. Aljurfa, “Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab),” Hematology/Oncology and Stem Cell Therapy, vol. 4, no. 2, pp. 100–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. de Marchi, S. de Vita, M. Fabris, C. A. Scott, and G. Ferraccioli, “Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature,” Haematologica, vol. 89, no. 4, article ECR03, 2004. View at Google Scholar · View at Scopus
  24. N. Talat, A. P. Belgaumkar, and K. M. Schulte, “Surgery in castlemans disease: a systematic review of 404 published cases,” Annals of Surgery, vol. 255, no. 4, pp. 677–684, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Grandadam, N. Dupin, V. Calvez et al., “Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells,” Journal of Infectious Diseases, vol. 175, no. 5, pp. 1198–2001, 1997. View at Google Scholar · View at Scopus
  26. M. Corbellino, G. Bestetti, C. Scalamogna et al., “Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy,” Blood, vol. 98, no. 12, pp. 3473–3475, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Gholam, J. M. Vantelon, A. Al-Jijakli, and J. H. Bourhis, “A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody,” Annals of Hematology, vol. 82, no. 12, pp. 766–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ide, E. Ogawa, K. Kasagi, Y. Kawachi, and T. Ogino, “Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab,” British Journal of Haematology, vol. 121, no. 5, pp. 818–819, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Nicoli, U. Familiari, M. Bosa et al., “HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma,” International Journal of Hematology, vol. 90, no. 3, pp. 392–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Cervera Grau, G. G. Esquerdo, C. L. Ferrándiz, H. B. Garcia, M. D. Castellano, and P. F. Moreno, “Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20,” Clinical and Translational Oncology, vol. 8, no. 7, pp. 540–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ide, Y. Kawachi, Y. Izumi, K. Kasagi, and T. Ogino, “Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab,” European Journal of Haematology, vol. 76, no. 2, pp. 119–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. M. Ocio, F. M. Sanchez-Guijo, M. Diez-Campelo et al., “Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena,” American Journal of Hematology, vol. 78, no. 4, pp. 302–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Marietta, S. Pozzi, M. Luppi et al., “Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report,” European Journal of Haematology, vol. 70, no. 3, pp. 181–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Anderson, M. Harris, S. E. Walsh, J. B. Houghton, and G. R. Morgenstern, “Autoimmune cytopenias in Castleman’s disease,” The American Journal of Clinical Pathology, vol. 94, no. 1, pp. 101–104, 1990. View at Google Scholar
  35. S. Suwannaroj, S. L. Elkins, and R. W. McMurray, “Systemic lupus erythematosus and Castleman's disease,” Journal of Rheumatology, vol. 26, no. 6, pp. 1400–1403, 1999. View at Google Scholar · View at Scopus
  36. J. P. Quinn, O. M. Gilligan, and M. Horgan, “Evan's syndrome complicating multicentric Castleman's disease—dramatic response to rituximab,” European Journal of Haematology, vol. 73, no. 5, pp. 384–385, 2004. View at Publisher · View at Google Scholar · View at Scopus